EIKN Eikon Therapeutics, Inc.
$11.05
Eikon Therapeutics, Inc. (EIKN) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $1.71 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.1% since its last earnings release on August 13, 2026.
Eikon Therapeutics Missed Consensus Estimates
Thursday, August 13, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($1.71)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$11.05
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
Sector
Healthcare
Industry
Biotechnology